BioCentury
ARTICLE | Clinical News

Idelvion albutrepenonacog alfa regulatory update

May 16, 2016 7:00 AM UTC

The European Commission approved Idelvion albutrepenonacog alfa from CSL for the treatment and prophylaxis of bleeding in patients with hemophilia B. The company said Idelvion will be launched in Euro...